Marco Bechtel
Paul Ehrlich Str. 40
Frankfurt Am Main, HE 60596, Germany
Frankfurt Am Main, HE 60596, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Discovery of synthetic G-quadruplex DNA as SARS-CoV-2 helicase inhibitor with antiviral, anti-inflammatory and antioxidative properties.
Journal: Cell death discovery
Published: November 20, 2025
Papaverine Targets STAT Signaling: A Dual-Action Therapy Option Against SARS-CoV-2.
Journal: Journal of medical virology
Published: November 16, 2024
Trifluridine for treatment of mpox infection in drug combinations in ophthalmic cell models.
Journal: Journal of medical virology
Published: August 31, 2023
Repurposing of the antibiotic nitroxoline for the treatment of mpox.
Journal: Journal of medical virology
Published: January 25, 2023
Drug Sensitivity of Currently Circulating Mpox Viruses.
Journal: The New England journal of medicine
Published: December 28, 2022
A Monoclonal Human Alveolar Epithelial Cell Line ("Arlo") with Pronounced Barrier Function for Studying Drug Permeability and Viral Infections.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: December 08, 2022
Omicron-induced interferon signaling prevents influenza A H1N1 and H5N1 virus infection.
Journal: Journal of medical virology
Published: September 26, 2022
USP22 controls type III interferon signaling and SARS-CoV-2 infection through activation of STING.
Journal: Cell death & disease
Published: March 14, 2022
A Potential Role of the CD47/SIRPalpha Axis in COVID-19 Pathogenesis.
Journal: Current issues in molecular biology
Published: August 25, 2021
Targeting the Pentose Phosphate Pathway for SARS-CoV-2 Therapy.
Journal: Metabolites
Published: August 23, 2021
Last Updated: 09/26/2026